References include the SURMOUNT-1 trial publication (Jastreboff et al., New England Journal of Medicine, 2022), the Mounjaro and Zepbound prescribing information (Eli Lilly, 2024), Liu et al., JAMA Internal Medicine, 2018 (steroid-induced hyperglycemia), and American Diabetes Association Standards of Care, 2024
Ozempic starts at a 0.25mg dose, then moves to a 0.5 or 1mg dose, with a 2mg dose available in some cases
The FDA has publicly warned about unapproved and falsely labeled GLP-1 products, including counterfeit and for research semaglutide sold directly to consumers
Consequently, the targeted inhibition of GOT1, in conjunction with its upstream and downstream pathways, or the combined inhibition of the major metabolic pathways of glutamine, has emerged as a promising novel strategy to overcome metabolic therapy resistance
Six cases were identified in VigiBasefour as 'bile duct cancer' and two as 'cholangiocarcinoma'potentially indicating overlapping diagnoses
However, the pharmacological treatment of obesity remains a complex challenge